Literature DB >> 18339461

Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.

Mary Dawn T Co1, Laura Orphin, John Cruz, Pamela Pazoles, Alan L Rothman, Francis A Ennis, Masanori Terajima.   

Abstract

Thirty adults were tested for humoral and cellular immune responses following immunization with the trivalent inactivated influenza vaccine. Modest but significant inverse correlations between the baseline and the fold changes in the number of IFNgamma-producing cells and the levels of neutralizing antibodies were observed. Specific increases in proliferative responses in the CD8 CD45RA+ population were noted after vaccination. Minimal correlations between neutralizing antibody titers and the number of IFNgamma-producing cells in terms of prevaccination levels or fold increases were observed. These results show specific increases in a CD8 T cell subset and discordant T and B responses induced by the trivalent inactivated influenza vaccine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339461      PMCID: PMC2440689          DOI: 10.1016/j.vaccine.2008.02.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  39 in total

1.  Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice.

Authors:  Gabrielle T Belz; Dominik Wodarz; Gabriela Diaz; Martin A Nowak; Peter C Doherty
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

Authors:  G M Gillespie; M R Wills; V Appay; C O'Callaghan; M Murphy; N Smith; P Sissons; S Rowland-Jones; J I Bell; P A Moss
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Scott A Harper; Keiji Fukuda; Timothy M Uyeki; Nancy J Cox; Carolyn B Bridges
Journal:  MMWR Recomm Rep       Date:  2004-05-28

4.  HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response.

Authors:  K Kuwano; M Scott; J F Young; F A Ennis
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

5.  Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8+ cytotoxic T cells.

Authors:  C D Mackenzie; P M Taylor; B A Askonas
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.

Authors:  Francis A Ennis; John Cruz; Walter E Demkowicz; Alan L Rothman; David J McClain
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

8.  Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly.

Authors:  Yuping Deng; Yu Jing; Ann E Campbell; Stefan Gravenstein
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

9.  Time to peak serum antibody response to influenza vaccine.

Authors:  S Rastogi; P A Gross; J Bonelli; S Dran; R A Levandowski; C Russo; M E Weksler; D Kaye; M Levison; E Abrutyn
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

10.  Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins.

Authors:  K Kuwano; T J Braciale; F A Ennis
Journal:  Viral Immunol       Date:  1989       Impact factor: 2.257

View more
  22 in total

1.  Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals.

Authors:  Mary Dawn T Co; John Cruz; Akira Takeda; Francis A Ennis; Masanori Terajima
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

2.  Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.

Authors:  Peng Yang; Li Zhang; Weixian Shi; Guilan Lu; Shujuan Cui; Xiaomin Peng; Daitao Zhang; Yimeng Liu; Huijie Liang; Xinghuo Pang; Quanyi Wang
Journal:  Influenza Other Respir Viruses       Date:  2011-12-30       Impact factor: 4.380

3.  Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.

Authors:  Mark W Lamere; Amy Moquin; F Eun-Hyung Lee; Ravi S Misra; Patrick J Blair; Laura Haynes; Troy D Randall; Frances E Lund; Denise A Kaminski
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

4.  Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.

Authors:  Edward A Stadtmauer; Dan T Vogl; Eline Luning Prak; Jean Boyer; Nicole A Aqui; Aaron P Rapoport; Kenyetta R McDonald; Xiaoling Hou; Heather Murphy; Rita Bhagat; Patricia A Mangan; Anne Chew; Elizabeth A Veloso; Bruce L Levine; Robert H Vonderheide; Abbas F Jawad; Carl H June; Kathleen E Sullivan
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

5.  Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination.

Authors:  Xi Li; Hongyu Miao; Alicia Henn; David J Topham; Hulin Wu; Martin S Zand; Tim R Mosmann
Journal:  Vaccine       Date:  2012-04-30       Impact factor: 3.641

6.  B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant.

Authors:  Jane Baer; Felix Santiago; Hongmei Yang; Hulin Wu; Jeanne Holden-Wiltse; John Treanor; David J Topham
Journal:  Vaccine       Date:  2009-11-21       Impact factor: 3.641

Review 7.  Cytotoxic T lymphocytes as immune-therapy in haematological practice.

Authors:  Ann M Leen; Helen E Heslop
Journal:  Br J Haematol       Date:  2008-08-07       Impact factor: 6.998

8.  Influenza A virus matrix protein 1-specific human CD8+ T-cell response induced in trivalent inactivated vaccine recipients.

Authors:  Masanori Terajima; John Cruz; Anita M Leporati; Laura Orphin; Jenny Aurielle B Babon; Mary Dawn T Co; Pamela Pazoles; Julie Jameson; Francis A Ennis
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

9.  In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses.

Authors:  Mary Dawn T Co; Laura Orphin; John Cruz; Pamela Pazoles; Karin M Green; James Potts; Anita M Leporati; Jenny Aurielle B Babon; James E Evans; Francis A Ennis; Masanori Terajima
Journal:  Vaccine       Date:  2008-10-31       Impact factor: 3.641

10.  Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults.

Authors:  Janet E McElhaney; Catherine Ewen; Xin Zhou; Kevin P Kane; Dongxu Xie; W David Hager; Mary Beth Barry; Alison Kleppinger; Yazhen Wang; R Chris Bleackley
Journal:  Vaccine       Date:  2009-03-03       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.